Literature DB >> 24682513

Proinflammatory human 6-sulfo LacNAc-positive dendritic cells accumulate in intestinal acute graft-versus-host disease.

Ulrich Sommer1, Brit Larsson2, Sebastian Tuve2, Rebekka Wehner3, Nick Zimmermann4, Michael Kramer2, Anja Kloβ3, Claudia Günther4, Jana Babatz3, Renate Schmelz3, Stefan Brückner3, Johannes Schetelig2, Martin Bornhäuser5, Knut Schäkel6, Michael Philipp Bachmann7, Daniela Aust1, Gustavo Baretton1, Marc Schmitz8.   

Abstract

Entities:  

Keywords:  acute graft versus host disease; b-sulfo LacNAc positive; dendritic cells; proinflammatory

Mesh：

Substances：

Year:  2014        PMID： 24682513      PMCID： PMC4040901          DOI： 10.3324/haematol.2013.101071

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host disease.

Authors:  Florent Malard; Céline Bossard; Eolia Brissot; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Jean-François Mosnier; Philippe Moreau; Marc Grégoire; Béatrice Gaugler; Mohamad Mohty
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

2.  Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells.

Authors:  M Bornhäuser; L Eger; U Oelschlaegel; S Auffermann-Gretzinger; A Kiani; J Schetelig; T Illmer; M Schaich; D Corbeil; C Thiede; G Ehninger
Journal:  Leukemia       Date:  2005-01       Impact factor: 11.528

3.  Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation.

Authors:  Susanne Auffermann-Gretzinger; Lars Eger; Martin Bornhäuser; Knut Schäkel; Uta Oelschlaegel; Markus Schaich; Thomas Illmer; Christian Thiede; Gerhard Ehninger
Journal:  Transplantation       Date:  2006-03-27       Impact factor: 4.939

4.  Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation.

Authors:  M Mohty; D Blaise; C Faucher; V-J Bardou; J-A Gastaut; P Viens; D Olive; B Gaugler
Journal:  Leukemia       Date:  2005-01       Impact factor: 11.528

5.  Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells.

Authors:  C Straube; R Wehner; M Wendisch; M Bornhäuser; M Bachmann; E P Rieber; M Schmitz
Journal:  Leukemia       Date:  2007-05-10       Impact factor: 11.528

Review 6.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

7.  6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells.

Authors:  Knut Schäkel; Reiji Kannagi; Bernhard Kniep; Yoshiko Goto; Chikako Mitsuoka; Jörg Zwirner; Afsaneh Soruri; Matthias von Kietzell; E Rieber
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

8.  G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity.

Authors:  Susanne H C Baumeister; Kristina Hölig; Martin Bornhäuser; Michael Meurer; E Peter Rieber; Knut Schäkel
Journal:  Blood       Date:  2007-07-06       Impact factor: 22.113

9.  Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes.

Authors:  Knut Schäkel; Matthias von Kietzell; Anja Hänsel; Annette Ebling; Livia Schulze; Michael Haase; Christian Semmler; Marika Sarfati; A Neil Barclay; Gwendalyn J Randolph; Michael Meurer; E Peter Rieber
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

10.  Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease.

Authors:  John Wilson; Hannah Cullup; Rohan Lourie; Yonghua Sheng; Anna Palkova; Kristen J Radford; Anne M Dickinson; Alison M Rice; Derek N J Hart; David J Munster
Journal:  J Exp Med       Date:  2009-01-26       Impact factor: 14.307
View more
  4 in total

1.  Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

Authors:  E Mimiola; O Marini; O Perbellini; A Micheletti; W Vermi; S Lonardi; C Costantini; E Meneghelli; A Andreini; C Bonetto; A Vassanelli; M Cantini; E Zoratti; D Massi; A Zamo'; A Leso; G Quaresmini; F Benedetti; G Pizzolo; M A Cassatella; C Tecchio
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

2.  Phenotype, Function, and Mobilization of 6-Sulfo LacNAc-Expressing Monocytes in Atopic Dermatitis.

Authors:  Wojciech Baran; Stephanie Oehrl; Fareed Ahmad; Thomas Döbel; Christina Alt; Angelika Buske-Kirschbaum; Marc Schmitz; Knut Schäkel
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

Review 3.  Human Dendritic Cell Subsets, Ontogeny, and Impact on HIV Infection.

Authors:  Jake William Rhodes; Orion Tong; Andrew Nicholas Harman; Stuart Grant Turville
Journal:  Front Immunol       Date:  2019-05-16       Impact factor: 7.561

4.  Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer.

Authors:  Felix Wagner; Ulrike Hölig; Friederike Wilczkowski; Ioana Plesca; Ulrich Sommer; Rebekka Wehner; Maximilian Kießler; Armin Jarosch; Katharina Flecke; Maia Arsova; Antje Tunger; Andreas Bogner; Christoph Reißfelder; Jürgen Weitz; Knut Schäkel; Esther G C Troost; Mechthild Krause; Gunnar Folprecht; Martin Bornhäuser; Michael P Bachmann; Daniela Aust; Gustavo Baretton; Marc Schmitz
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.